100
Participants
Start Date
February 14, 2022
Primary Completion Date
February 14, 2026
Study Completion Date
February 28, 2026
Heparin solution
3 ml saline solution containing 5000 IU heparin.
Anti-adhesion barrier gel
2 ml biodegradable barrier gel containing sodium hyaluronate (10 mg/ml), sodium chloride (8.5 mg/ml), disodium hydrogen phosphate (0.34mg/ml), sodium dihydrogen phosphate (0.14 mg/ml) and water for injection (QS to weight).
RECRUITING
Nadezhda Women's Health Hospital, Sofia
RECRUITING
Nadezhda Women's Health Hospital, Sofia
Nadezhda Women's Health Hospital
OTHER